RTW Investments LP bought a new stake in Bovie Medical Co. (NYSEAMERICAN:BVX) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,139,600 shares of the medical device company’s stock, valued at approximately $3,852,000. Bovie Medical accounts for about 0.7% of RTW Investments LP’s portfolio, making the stock its 23rd biggest position. RTW Investments LP owned about 3.47% of Bovie Medical at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Archon Capital Management LLC purchased a new stake in shares of Bovie Medical in the third quarter valued at $254,000. Perkins Capital Management Inc. grew its holdings in shares of Bovie Medical by 4.0% in the third quarter. Perkins Capital Management Inc. now owns 623,685 shares of the medical device company’s stock worth $2,108,000 after purchasing an additional 23,868 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its holdings in shares of Bovie Medical by 36.2% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 109,950 shares of the medical device company’s stock worth $372,000 after purchasing an additional 29,200 shares during the last quarter. Virtu KCG Holdings LLC grew its holdings in shares of Bovie Medical by 23.5% in the second quarter. Virtu KCG Holdings LLC now owns 42,941 shares of the medical device company’s stock worth $106,000 after purchasing an additional 8,182 shares during the last quarter. Finally, Northern Trust Corp grew its holdings in shares of Bovie Medical by 1.9% in the second quarter. Northern Trust Corp now owns 80,699 shares of the medical device company’s stock worth $199,000 after purchasing an additional 1,534 shares during the last quarter.

Bovie Medical Co. (BVX) traded down $0.04 during midday trading on Wednesday, hitting $2.92. 29,300 shares of the stock were exchanged, compared to its average volume of 114,015. Bovie Medical Co. has a 12-month low of $1.87 and a 12-month high of $4.29.

A number of research analysts have recently commented on the stock. ValuEngine cut shares of Bovie Medical from a “hold” rating to a “sell” rating in a report on Monday, November 6th. Zacks Investment Research upgraded shares of Bovie Medical from a “sell” rating to a “hold” rating in a report on Monday, October 16th.

COPYRIGHT VIOLATION WARNING: This report was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/12/06/rtw-investments-lp-invests-3-85-million-in-bovie-medical-co-bvx.html.

Bovie Medical Profile

Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.

Want to see what other hedge funds are holding BVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bovie Medical Co. (NYSEAMERICAN:BVX).

Institutional Ownership by Quarter for Bovie Medical (NYSEAMERICAN:BVX)

Receive News & Stock Ratings for Bovie Medical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bovie Medical Co. and related stocks with our FREE daily email newsletter.